权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Molecular Mechanisms of the Dysregulated Immune Response to Ebola Virus

埃博拉病毒免疫反应失调的分子机制

基本信息

批准号：
10602482
负责人：
Alexander Bukreyev
金额：
$ 221.31万
依托单位：
UNIVERSITY OF TEXAS MED BR GALVESTON
依托单位国家：
美国
项目类别：
财政年份：
2021
资助国家：
美国
起止时间：
2021-04-15 至 2026-03-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10602482
关键词：
2019-nCoV Acute Address Africa Alternative Splicing Apoptosis Behavior Bioinformatics COVID-19 COVID-19 pandemic Cells Cessation of life Collaborations Communication Complex Data Democratic Republic of the Congo Dendritic Cells Development Disease Outbreaks Ebola Hemorrhagic Fever Ebola virus Ebola virus envelope glycoprotein Epigenetic Process Evaluation Event Experimental Designs Gene Expression Genetic Transcription Histone Deacetylase Human Immune Immune Tolerance Immune response Individual Infection Inflammation Interferons Investigation Knowledge Lassa virus Lead Lymphopenia Marburgvirus Mass Spectrum Analysis Massive Parallel Sequencing Modeling Modification Molecular NF-kappa B Outcome Paint Pathogenesis Pathogenicity Pathologic Phosphorylation Population Post-Translational Protein Processing Program Research Project Grants Public Health RNA Research Research Project Grants Role Running Sampling Strategic Planning T-Lymphocyte TLR4 gene Testing Tissues Translation Alteration Ubiquitination Validation Viral Hemorrhagic Fevers Virus Virus Diseases Work antagonist cell type cytokine epidemic virus experimental study gene product improved outcome individual response mRNA Translation medical countermeasure network models nonhuman primate novel therapeutics outbreak control posttranscriptional programs proteogenomics response tool transcription factor

项目摘要

OVERALL: PROJECT SUMMARY/ABSTRACT The central hypothesis of the proposed P01 Program is that Ebola virus infection leads to cell-type specific transcriptional, posttranscriptional, and posttranslational alterations that create aberrant counterproductive responses of immune cells, leading to a dysregulated immune response, which paradoxically produces “immune paralysis” and hyperinflammation. To address the hypothesis, three Research Projects are proposed. Research Project 1 focuses on pathogenic mechanisms at the transcriptional level, while Research Project 2 focuses on posttranscriptional events, and Research Project 3 focuses on posttranslational modifications, each contributing to the dysregulated immune response to Ebola virus. The dysregulated immune response is responsible for most of the pathogenesis observed in Ebola virus disease. All projects require the BSL-4 Core (Core B), which will be responsible for performing infections of human immune and nonimmune cells, nonhuman primates, and the initial steps of experiments that involve infectious virus. Importantly, Core B will provide each of the research projects samples from the same experimental samples insuring that data from each project can be compared directly—this is a unique feature of this P01 Program. The Proteogenomics Core (Core C) will be responsible for massive parallel sequencing and mass spectrometry-based studies. The Bioinformatics and Modeling Core (Core D) is critical for generating tools employed in the experimental designs, including statistical help for OMICS experiments, analyzing OMICS data and integrating OMICS data into networks that model the behavior of various cell populations infected with EBOV. The work done in Core D will synthesize a model to explain how transcriptional, posttranscriptional, and posttranslational responses of individual cell populations lead to immune dysregulation. The comprehensive picture painted by this collaborative effort will revolutionize our understanding of the immunopathogenesis of severe acute viral infections (e.g., immune imbalance seen in COVID-19). The Administrative Core (Core A) will be responsible for strategic planning, continual evaluation, and communication and coordination of activities among the various components of the project according to a detailed management plan. The expected outcomes will contribute substantially to our knowledge of the fundamental mechanisms of the immunopathogenesis of EBOV infections toward the development of effective countermeasures. The expected outcomes will include (1) detailed knowledge of transcriptional mechanisms leading to the dysregulated immune response to EBOV, (2) elucidation of the role of posttranscriptional mechanisms in the dysregulated immune response to EBOV, (3) elucidation of the role of posttranslational mechanisms in the dysregulated immune response to EBOV, and (4) experimental validation of the identified pathogenic mechanisms and their targeting. The proposed tightly coordinated and comprehensive analysis has not been done before for any virus.

总体：项目总结/摘要拟议的P01计划的中心假设是，埃博拉病毒感染导致细胞类型特异性转录、转录后和翻译后改变，造成异常的反作用，免疫细胞的反应，导致免疫反应失调，这矛盾地产生“免疫”。麻痹”和炎症过度。为了解决这一假设，提出了三个研究项目。研究项目1侧重于转录水平的致病机制，而研究项目2侧重于转录后事件，研究项目3侧重于翻译后修饰，每个贡献与埃博拉病毒免疫反应失调有关免疫反应失调是造成大部分疾病的原因埃博拉病毒病的发病机制。所有项目都需要BSL-4核心（核心B），该核心将负责执行人类感染免疫和非免疫细胞，非人灵长类动物，以及涉及感染性实验的初始步骤，病毒重要的是，核心B将提供来自同一实验的每个研究项目样本。样本确保每个项目的数据可以直接进行比较-这是P01的独特功能程序.蛋白质基因组学核心（Core C）将负责大规模并行测序和质量分析。基于光谱学的研究生物信息学和建模核心（核心D）对于生成工具至关重要在实验设计中使用，包括OMICS实验的统计帮助，分析OMICS数据并将OMICS数据整合到网络中，模拟感染的各种细胞群的行为。 EBOV。核心D中所做的工作将综合一个模型来解释转录，转录后，单个细胞群的翻译后应答导致免疫失调。综合这项合作所描绘的画面将彻底改变我们对免疫发病机制的理解。严重的急性病毒感染（例如，COVID-19中出现的免疫失衡）。核心A（Core A）负责战略规划、持续评估、沟通和活动协调根据详细的管理计划，在项目的各个组成部分之间进行协调。预期的结果将大大有助于我们了解的基本机制， EBOV感染的免疫发病机制朝着制定有效对策的方向发展。预期结果将包括（1）详细了解导致免疫失调的转录机制，（2）阐明转录后机制在免疫失调中的作用，（3）阐明了翻译后机制在免疫失调中的作用，对EBOV的应答，以及（4）鉴定的致病机制及其靶向的实验验证。所提议的紧密协调和全面的分析以前从未对任何病毒进行过。